Close

Ratings by Jones Trading (Soumit Roy)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/30/2024 Adaptimmune Therapeutics plc ADAP Maintain Buy
(N/A)
 
 
  Details
5/29/2024 CervoMed CRVO New Coverage Buy
(N/A)
18.69
(19.76)
5.72% Details
5/15/2024 Bolt Biotherapeutics, Inc. BOLT Downgrade Hold
(Buy)
1.32
(0.77)
-41.67% Details
5/9/2024 Anavex Life Sciences AVXL Maintain Buy
(N/A)
 
 
  Details
4/29/2024 Deciphera DCPH Downgrade Hold
(Buy)
14.65
(25.59)
74.68% Details
4/25/2024 Acrivon Therapeutics Inc ACRV Maintain Buy
(N/A)
 
 
  Details
4/24/2024 Day One Biopharmaceuticals DAWN Maintain Buy
(N/A)
 
 
  Details
4/16/2024 Cullinan Oncology Inc. CGEM Maintain Buy
(N/A)
 
 
  Details
4/16/2024 Janux Therapeutics JANX New Coverage Buy
(N/A)
52.65
(42.37)
-19.53% Details
4/11/2024 Monopar Therapeutics MNPR Upgrade Buy
(Hold)
0.64
(0.91)
42.19% Details
3/27/2024 Aptose Biosciences APTO Maintain Buy
(N/A)
 
 
  Details
3/20/2024 Precision BioSciences Inc. DTIL Maintain Buy
(N/A)
 
 
  Details
3/15/2024 Day One Biopharmaceuticals DAWN Maintain Buy
(N/A)
 
 
  Details
3/13/2024 IN8bio Inc. INAB New Coverage Buy
(N/A)
1.27
(1.68)
32.28% Details
3/7/2024 Adaptimmune Therapeutics plc ADAP Upgrade Buy
(Hold)
1.71
(1.04)
-39.18% Details
2/13/2024 Adicet Bio Inc. ACET Upgrade Buy
(Hold)
3.12
(1.45)
-53.53% Details
10/30/2023 Deciphera DCPH Upgrade Buy
(Hold)
10.15
(25.59)
152.12% Details
10/9/2023 Mirati Therapeutics MRTX Downgrade Hold
(Buy)
62.38
(58.70)
-5.9% Details
10/5/2023 Cullinan Oncology Inc. CGEM New Coverage Buy
(N/A)
8.12
(21.80)
168.47% Details
8/18/2023 Tracon Pharmaceuticals TCON Downgrade Hold
(Buy)
0.20
(0.97)
385% Details
8/18/2023 Acrivon Therapeutics Inc ACRV New Coverage Buy
(N/A)
11.26
(7.72)
-31.44% Details
8/10/2023 Monopar Therapeutics MNPR Downgrade Hold
(Buy)
0.73
(0.91)
24.66% Details
5/24/2023 Oncolytics Biotech ONCY New Coverage Buy
(N/A)
1.91
(1.03)
-46.07% Details
5/22/2023 Rain Therapeutics RAIN Downgrade Hold
(Buy)
9.93
(1.21)
-87.81% Details
4/12/2023 Aeglea Biotherapeutics AGLE Downgrade Hold
(Buy)
0.26
(12.01)
4519.23% Details
3/6/2023 Adaptimmune Therapeutics plc ADAP Downgrade Hold
(Buy)
1.76
(1.04)
-40.91% Details
1/6/2023 Deciphera DCPH Upgrade Hold
(Sell)
19.76
(25.59)
29.5% Details
12/13/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
12/2/2022 Anavex Life Sciences AVXL Maintain Buy
(N/A)
 
 
  Details
11/16/2022 Inhibikase Therapeutics Inc IKT Downgrade Hold
(Buy)
0.54
(1.53)
183.33% Details
11/8/2022 HCW Biologics Inc. HCWB New Coverage Buy
(N/A)
2.25
(1.12)
-50.22% Details
10/31/2022 AVEO Pharmaceuticals AVEO Downgrade Hold
(Buy)
14.77
(15.00)
1.56% Details
9/6/2022 Day One Biopharmaceuticals DAWN New Coverage Buy
(N/A)
23.76
(12.92)
-45.62% Details
8/12/2022 Infinity Pharmaceutical INFI Downgrade Hold
(Buy)
1.08
(0.04)
-96.3% Details
8/1/2022 Aileron Therapeutics Inc ALRN Downgrade Hold
(Buy)
0.19
(3.25)
1610.53% Details
7/20/2022 Vascular Biogenics Ltd VBLT Downgrade Hold
(Buy)
2.05
(0.16)
-92.2% Details
6/30/2022 Aileron Therapeutics Inc ALRN Downgrade Hold
(Buy)
0.41
(3.25)
692.68% Details
6/23/2022 Rain Therapeutics RAIN New Coverage Buy
(N/A)
2.36
(1.21)
-48.73% Details
5/10/2022 Precision BioSciences Inc. DTIL Maintain Buy
(N/A)
 
 
  Details
4/1/2022 Silverback Therapeutics SBTX Downgrade Hold
(Buy)
3.51
(5.87)
67.24% Details
3/14/2022 AVEO Pharmaceuticals AVEO New Coverage Buy
(N/A)
3.78
(15.00)
296.83% Details
3/26/2021 Celyad SA CYAD Downgrade Hold
(Buy)
7.61
(0.47)
-93.82% Details
3/17/2021 Cassava Sciences SAVA New Coverage Buy
(N/A)
52.16
(19.89)
-61.87% Details
2/22/2021 Aptose Biosciences APTO New Coverage Buy
(N/A)
4.31
(0.93)
-78.42% Details
7/2/2020 T2 Biosystems, Inc TTOO Maintain Buy
(N/A)
 
 
  Details
6/19/2020 Trillium Therapeutics TRIL New Coverage Buy
(N/A)
8.23
(18.44)
124.06% Details
5/29/2020 Adaptimmune Therapeutics plc ADAP Upgrade Buy
(Hold)
4.86
(1.04)
-78.6% Details
4/29/2020 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Hold
(Buy)
93.91
(95.51)
1.7% Details
8/1/2019 T2 Biosystems, Inc TTOO Downgrade Hold
(Buy)
1.44
(4.80)
233.33% Details